SNBP - Sun BioPharma, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development1,7832,5932,5042,852
Selling General and Administrative2,1083,4232,6642,267
Non Recurring----
Total Operating Expenses3,8916,0165,1685,119
Operating Income or Loss-3,891-6,016-5,168-5,119
Income from Continuing Operations
Total Other Income/Expenses Net-2,268-4,894-285-564
Earnings Before Interest and Taxes-3,891-6,016-5,168-5,119
Interest Expense-1,814-1,617-180-183
Income Before Tax-6,159-10,910-5,453-5,683
Income Tax Expense-254-536-341-756
Minority Interest----
Net Income From Continuing Ops-5,905-10,374-5,112-4,927
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,905-10,374-5,112-4,927
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,905-10,374-5,112-4,927